Platbio
Latest round
- Series A
Last raised
- Jan 2020
Total raised
- $2.8M
Investors
- 4
About Platbio
a. Platbio operates as a biotechnology company focused on novel drug development using an innovative drug discovery platform. The company leverages a proprietary translational research approach to address unmet medical needs, particularly in cancer treatment. In October 2021, Platbio Inc. at KRW 64 billion post-money. Platbio focuses on developing new drugs using its proprietary drug discovery platform, PRIINT™. This platform integrates advanced genomics and proteomics for the identification and isolation of novel therapeutic targets, particularly in oncology. Platbio utilizes orthotopic animal models to mimic tumor-environment interactions, providing a more accurate representation of human cancer for preclinical research. The company’s services include drug efficacy evaluation, therapeutic regimen development, and drug repositioning strategies. Platbio also offers CRO and consulting services for nonclinical and clinical development, aiming to streamline drug discovery and improve precision in translational research.
Who invested in Platbio
4 investors across 1 round
See all investors in Platbio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 10, 2020
Amount
$2.8M
Investors
Questions about Platbio
Who invested in Platbio?
Platbio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Platbio raised?
Platbio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Platbio last raise money?
Platbio's most recent round on record is a Series A, in Jan 2020.
What does Platbio do?
Platbio is a biotechnology company.
Where is Platbio headquartered?
Platbio is headquartered in Suwon, South Korea.
Which VCs invest in companies like Platbio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Platbio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Platbio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.